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A B S T R A C T   
Cell transplantation has been proved the promising therapeutic effects on intervertebral disc degeneration 
(IVDD). However, the increased levels of reactive oxygen species (ROS) in the degenerated region will impede 
the efficiency of human adipose-derived stem cells (human ADSCs) transplantation therapy. It inhibits human 
ADSCs proliferation, and increases human ADSCs apoptosis. Herein, we firstly devised a novel amphiphilic 
copolymer PEG-PAPO, which could self-assemble into a nanosized micelle and load lipophilic kartogenin (KGN), 
as a single complex (PAKM). It was an injectable esterase-responsive micelle, and showed controlled release 
ability of KGN and apocynin (APO). Oxidative stimulation promoted the esterase activity in human ADSCs, 
which accelerate degradation of esterase-responsive micelle. Compared its monomer, the PAKM micelle 
possessed better bioactivities, which were attributed to their synergistic effect. It enhanced the viability, auto-
phagic activation (P62, LC3 II), ECM-related transcription factor (SOX9), and ECM (Collagen II, Aggrecan) 
maintenance in human ADSCs. Furthermore, it is demonstrated that the injection of PAKM with human ADSCs 
yielded higher disc height and water content in rats. Therefore, PAKM micelles perform promoting cell survival 
and differentiation effects, and may be a potential therapeutic agent for IVDD.   
1. Introduction 
Intervertebral disc degeneration (IVDD) is the main cause of lower 
back pain, which can create high medical expenses [1,2]. The nucleus 
pulposus (NP), annulus fibrosus, and endplate are the important com-
ponents in intervertebral disc (IVD) [3]. Annulus fibrosus is made up of a 
series of 15–25 concentric rings, or lamellae, with the collagen fibers 
lying parallel within each lamella. Endplate is a thin horizontal layer of 
hyaline cartilage, which interfaces the disc and the vertebral body. The 
NP is a fiber reinforced, isotropic, gelatinous, water-rich, and swollen 
core, which is the main structure in IVD. It provides compressive resis-
tance as well as a center of rotation for movement [4,5]. Many 
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pathological factors, including aging, trauma, genetics or other exoge-
nous stimuli result in IVDD [6]. Meanwhile, IVDD is characterized by 
various structural and histological changes as well as an altered 
expression of extracellular matrix (ECM) and inflammatory markers [7]. 
In the past decade, supplementation of exogenous human adipose 
mesenchymal stem cells (human ADSCs) has shown therapeutic effects 
on IVDD in both basic research and preclinical studies [6,8,9]. First, the 
NP area is recognized as an immune privileged region. This character-
istic limits immune responses to exogenous stem cell transplantation 
[10]. Transplantation of pre-differentiated human ADSCs can also 
augment the number of functional cells and ECM, thus maintaining IVD 
functions [11,12]. Therefore, exogenous human ADSCs transplantation 
is a promising treatment target for IVDD repair [9]. However, the effi-
ciency of cell differentiation and survival rate of transplanted cells in 
IVD are major obstacles. After stem-cell transplantation, many injected 
cells rapidly become undetectable, suggesting that the viability and 
functionality of these cells might be dramatically damaged [6,8,13]. The 
main reason for this is the harsh microenvironment caused by nonspe-
cific inflammation and excessive reactive oxygen species (ROS) at the 
lesion site [14]. Excessive ROS levels in the degenerated area inhibits 
human ADSCs proliferation, increases apoptosis, and reduces the effi-
ciency of IVDD treatment. Oxidative stress also causes 
hyper-peroxidation, protein carbonylation, and DNA damage to human 
ADSCs [15,16]. Consequently, it is necessary to find methods to decrease 
ROS levels in the degenerated disc microenvironment to facilitate the 
viability and functionality of human ADSCs. 
To solve these therapeutic problems, an esterase-responsive apoc-
ynin (APO)-based amphiphilic polymer micelle loaded with kartogenin 
(KGN), as a single complex (PAKM), was designed for IVDD treatment. 
The PAKM provided sustained delivery of KGN and APO in a single 
system. APO is a naturally occurring methoxy-substituted catechol, used 
experimentally as an NADPH oxidase inhibitor [17,18]. Its antioxidant 
effects arise through its inhibition of translocation of the cytosolic 
component p47phox of the NADPH-oxidase complex to the cell mem-
brane [19–22]. Several studies have shown that pretreatment with APO 
facilitates the therapeutic efficacy of stem cells by improving the 
anti-aging and anti-apoptotic capability [23,24]. Meanwhile, lipophilic 
KGN were loaded in the micelle. Others have shown that stem cells 
induced by KGN could differentiate into an NP-like phenotype, and 
contribute to attenuation of intervertebral disc degeneration [25]. 
Therefore, we suppose that APO stimulate the proliferation and survival 
rate of human ADSCs, which could be further developed into an NP-like 
phenotype by KGN. The combination of APO and KGN might have a 
synergetic effect in ameliorating the function of the degenerative disc. 
However, the delivery of APO and KGN into the NP area still faces ob-
stacles due to the lack of vascularization of the intervertebral disc and 
the short-lived effect of the bioactive agents. Focus has been shifted 
towards an injectable delivery system with advantages such as pro-
longed biological drug activity, lower systemic drug concentrations, and 
decreased administration frequencies. Herein, a polymer micelle-based 
drug delivery system was developed, in which the APO drug is linked 
onto the polymer chain via an esterase-responsive phenolic ester bond 
and KGN was physically loaded in the core of the micelle. Transplanted 
human ADSCs increased esterase activity under oxidative stress, initi-
ating APO and KGN release at the disc lesion site. Overall, PAKM showed 
an accurate and controlled delivery of the APO and KGN, which protects 
human ADSCs from oxidative stress and promotes human ADSCs to 
differentiate into an NP-like phenotype (see Scheme 1). 
2. Materials and methods 
2.1. Materials 
2-hydroxyethyl methacrylate (HEMA), triphosgene, 2-hydroxyethyl 
methacrylate (HEMA), apocynin (APO), kartogenin (KGN), 1-(3-Dime-
thylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC), 4-dime-
thylaminopyridine (DMAP), 2-Hydroxy-2-methylpropiophenone and 2, 
2′-azobis (2-methylpropionitrile) (AIBN), polyethyleneglycol 
(PEG5000-OH) were purchased from Energy Chemical (Shanghai, 
China). 
2.2. Synthesis of PEG-PETTC 
4-Cyano-4-(2-phenylethanesulfanylthiocarbonyl) sulfanylpentanoic 
Acid (PETTC, 1.02 g, 0.003 mol) was prepared according to the litera-
ture [26], PEG5000-OH (5 g, 0.001 mol), DMAP (0.12 g, 0.001 mol) 
were dissolved in 100 mL DCM, EDC (0.86 g, 0.0045 mol) was dropwise 
added into the above solution under ice bath. After 24 h at room tem-
perature, the DCM was removed and the mixture was precipitated in 
diethyl ether. The obtained product was light yellow solid (3.8g, 71%) 
2.3. Synthesis of monomer 2-(((4-acetyl-2-methoxyphenoxy)carbonyl) 
oxy)ethyl methacrylate (HAPO) 
Hydroxyethyl methacrylate (HEMA, 3.9 g, 0.03 mmol), triphosgene 
(2.97 g, 0.01 mol) was dissolved in 50 mL THF, and triethylamine (3 g, 
0.03 mol) in dry THF (10 mL) was added into the above solution at 0 ◦C. 
After 1 h, triethylamine hydrochloride was removed by filtering, and the 
Scheme 1. General schematic of synthesis of an injectable and degradable antioxidant polymer micelle (PAKM) as stem cell therapy for intervertebral disc 
degeneration. human ADSCs is represented by hADSCs as follow: hADSCs = Human ADSCs. 
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solution was mixed with apocynin (APO, 5 g, 0.03 mol), and triethyl-
amine (3 g, 0.03 mol) in dry THF (10 mL) was added into the solution at 
0 ◦C, the reaction was conducted at room temperature for 24 h. After 
removing the triethylamine hydrochloride by filtration, THF was 
removed by rotary evaporation, and the crude product was washed with 
1 M HCl and brine, and purified by column chromatography (silica gel, 
hexane: ethyl acetate = 3:1) to afford 8.2 g (84.5%). 1H NMR (400 MHz, 
CDCl3) δ = 7.66–7.49 (m, 2 H), 7.24 (m, 1 H), 6.2 (3, 1 H), 5.6 (s, 0 H), 
4.49 (m, 3 H), 3.91 (s, 3 H), 2.61 (s, 3 H), 2.00 (s, 3 H). 
2.4. Synthesis of block copolymer PEG-PAPO 
PEG-PETTC (0.20 g, 0.037 mmol), HAPO (0.20 g, 0.6 mmol), AIBN 
(6.56 mg, 0.04 mmol), and DMF (2 mL) were charged into a Schlenk 
tube with a magnet. After removing the O2 by N2, the reaction was 
heated to 70 ◦C for 15 h. PEG-PAPO was obtained by precipitating in 
diethyl ether. (0.23g 57.5%) 1H NMR (400 MHz, DMSO) δ 7.55 (32H), 
7.26 (6H), 4.24 (64 H), 3.80 (48 H), 3.51 (454 H), 2.53 (48 H). 
2.5. Preparation and characterization of the micelle 
DMSO (0.5 mL) was used to dissolved PEG-PAPO (40 mg) and KGN 
(4 mg). The solution was dropwise added into deionized water (8 mL) 
with strong stirring, and DMSO was removed by dialyzing. Dynamic 
light scattering (DLS) spectrometer (Nano series ZEN3600, Malvern In-
struments Ltd., UK) was used to characterize the size and morphology of 
the micelles. 
2.6. Esterase degradation measurement 
The micelle was dissolved in PBS and divided into pH 7.4 group and 
pH 7.4 with esterase (120 U/mL) group. A nanoparticle solution for each 
group (1 mL, containing 10 mg polymer) and esterase were sealed in a 
dialysis bag with a molecular weight cut off at 3500 Da and dialyzed in 
39 mL of PBS with 2% Tween 80. At regular intervals, a 200 μL of liquid 
outside the bag was taken out for HPLC analysis. 
2.7. KGN release measurement 
Micelle (1 mL) solution was sealed in a dialysis bag with a molecular 
weight cut off at 3500 Da, and the dialysis bag was immersed in 39 mL 
PBS and incubated in 37 ◦C. At regular intervals, a 200 μL of liquid 
outside the bag was taken out for HPLC analysis. 
2.8. Cell culture 
Human ADSCs was provided by Cyagen Biosciences (HUXMD- 
01001; Guangzhou, China). Four tubes of primary human ADSCs cells, 
from the lipoaspirate of different donors, were obtained. The medium 
from Cyagen Biosciences (HUXMD-90011; Guangzhou, China, Table S2) 
was used to culture human ADSCs in a humidified incubator at 37 ◦C 
with 5% CO2. The culture medium replacement time was about 3 days. 
The subsequent experiments used the human ADSCs at passages 2–4. 
The basal differentiation media contained Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM L- 
glutamine, and 1% penicillin–streptomycin solution (Table S2). The 
experimental condition of human ADSCs pellets was conducted as fol-
lows: A total of 3 × 105 human ADSCs were placed in a 15 mL poly-
propylene tube, and centrifuged at 500×g for 5 min. The pellets were 
cultured at 37 ◦C with 5% CO2 in 500 μL of differentiation medium 
supplemented with 1% insulin-transferrin-selenium supplement for 21 
days. The pellets were fixed in 4% paraformaldehyde, embedded in O.C. 
T. compound, and cut into 12 μm sections. Then, nucleus pulposus dif-
ferentiation was assessed by Safranin O staining and fluorescence mi-
croscopy observation. 
2.9. H2O2-induced human ADSCs and treatment 
Five groups were prepared: the human ADSCs were cultured with or 
without APO, KGN, and PAKM. H2O2 (0.4 mmol/L) were added to each 
group for 24 h. The groups were divided into (1) Control, (2) H202, (3) 
APO + H2O2, (4) KGN + H2O2, and (5) PAKM + H2O2. The micelle were 
filtered and prepared for further study. 
2.10. Cellular esterase evaluation 
Human ADSCs were incubated with H2O2 (0.4 mmol/L) overnight. 
Fluorescein diacetate (FDA) (Sigma-Aldrich) was dissolved with DMSO 
at 10 mg/mL as a storage solution, and then diluted it to 1 mg/mL with 
PBS as a working solution. Finally, cells were cultured with 5 μg/mL 
FDA in medium for 30 min before cellular esterase evaluation. The 
image was taken using fluorescence microscope (Leica). 
2.11. Cell viability and apoptosis evaluation 
CCK-8 kit (Beyotime, China)was used to test the cytotoxicity and 
proliferation of cells cultured with APO, KGN, and PAKM. The live/dead 
viability assay kit (Us everbright, China) was used to conduct Live/dead 
assays. Human ADSCs were incubated with fluorescein diacetate (5 
μM)/propidium iodide (20 μM) at 37 ◦C in the dark for 5 min. The 
fluorescent image was taken using fluorescence microscope (Leica). 
Annexin V-FITC/PI Apoptosis Detection Kit (Solarbio, China) was used 
to measure the cell apoptosis, and then analyzed by the flow cytometer 
(BD Biosciences, USA). 
2.12. Intracellular ROS detection 
After treatment with or without H2O2 for 24h, human ADSCs 
cultured with APO, KGN, and PAKM were incubated with 20 μM 
dichloro-dihydro-fluorescein diacetate (DCFH-DA) at 37 ◦C for 0.5 h in 
the dark. Then cells were washed three times with PBS. The intracellular 
ROS level was measured by fluorescence microscope (Leica). 
2.13. Assessment of autophagy 
For assessment of autophagy, the secretion of LC3 II was observed by 
immunofluorescence. The samples were fixed with 4% formalin for 20 
min, and then permeabilized with 0.3%Triton X-100 (W/V) in PBS for 
30 min. After blockage by 5% BSA for 15 min, the primary antibody LC3 
II (1:200 dilution, Abcam, USA) was added, and incubated at 4 ◦C over 
night, followed by the incubation of the secondary antibody Alexa Fluor 
647-labeled Goat Anti-Rabbit IgG (1:500 dilution, Beyotime, China) for 
12 h. The images were captured by an fluorescence microscope (Leica). 
The dots of LC3 II were counted by image J software. 
2.14. qRT-PCR assessment 
RNAiso reagent (TaKaRa Bio,Japan) was used to isolate total RNA. 
Reverse transcription was conducted by a PrimeScript RT reagent kit 
(TaKaRa, Bio, Japan). StepOnePlus Real-time PCR System (Applied 
Biosystems, CA, USA) and a SYBR® Premix Ex TaqTM kit (TaKaRa Bio, 
Japan) were used to conduct qRT-PCR. We chose 18s rRNA as the 
Housekeeping gene. 2–△△Ct method was used to calculate the result. 
Sangon Biotech (Shanghai, China) provided all the primers used in this 
study. Table 1 listed all the primers sequences. 
2.15. Western blot assessment 
Human ADSCs were cultured with APO, KGN, and PAKM. RIPA lysis 
buffer including a protease inhibitor cocktail (Sigma-Aldrich) was used 
to lyse the cells for 30 min, and vortexed every 10 min. Then, the so-
lution was centrifuged at 12,500 g at 4 ◦C for 15 min. The BCA protein 
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assay kit (Pierce, Waltham, MA, USA) was used to quantify the protein in 
the supernatant. SDS-PAGE was used to separate protein at 80 V for 1.5 
h. Then protein was transferred onto 2.2 μm polyvinylidene fluoride 
membranes (Millipore) at 250 mA for 2 h. 5% bovine serum albumin 
(Sigma-Aldrich) was used to block the membranes at room temperature 
for 1 h. Then the membranes were treated with the following primary 
antibodies at 4 ◦C overnight: ACAN (1:1000, Abcam), COL2 (1:1000; 
Abcam), SOX9 (1:1000, Abcam), KRT19 (1:1000, Cell Signaling Tech-
nology), COX2 (1:1000, Abcam), MMP-13 (1:1000, Abcam), and 
GAPDH (1:1000; Santa Cruz, USA). Finally, the membranes were treated 
with horseradish peroxidase (HRP)-conjugated secondary antibodies 
(Cell Signaling Technology) at room temperature for 1 h. An enhanced 
chemiluminescence kit (Millipore) was used to detect the 
immunoreactivity. 
2.16. Animal surgery 
The Sprague–Dawley rats were purchased from the Shanghai Labo-
ratory Animal Center of the Chinese Academy of Sciences. The study was 
approved by the local authorities (the Second Affiliated Hospital of 
Zhejiang University School of Medicine, China). Our previous study 
described the surgical procedure used in this study [27]. The rats were 
intraperitoneally injected with 1% pentobarbital sodium (Sigma 
Aldrich, St. Louis, MO, 0.4 mL/kg). Palpation was used to determine the 
intervertebral discs of coccygeal (Co) vertebrae Co7/Co8, Co8/Co9, and 
Co9/Co10. Then, we inserted a 20-G sterile needle with a handmade 
stopper into the middle of the disc for a depth of 5 mm, rotated 360◦, and 
held for 30 s. 80 male rats with an average weight of 270 g at the day of 
surgery were randomly divided into four groups: The control group (NC) 
(without needle puncture); The degeneration group (DC) (with needle 
puncture and PBS injection); The PAKM (with needle puncture and 
PAKM injection); And the PAKM with human ADSCs group (PAKMA) 
(with needle puncture and PAKM with human ADSCs injection). 2 μl of 
material was injected into the NP of Co7/Co8, Co8/Co9, and Co9/Co10 
by a 31-G needle. Fifteen-independent IVDs (5 rats) of different groups 
obtained at 0, 4, 8, and 16 weeks for futher experiment. 
2.17. Disc height evaluation 
Molybdenum target (GEMammography DMR Bucky 18 × 24, GE 
Healthcare, Little Chalfont, UK) was used to evaluate disc height at 0 and 
16 weeks. We put the rats in the prone position, and straightened the 
tail. A computed radiographic plate system (AGFA Diagnostic Center 
Compact Plus, AGFA HealthCare, Mortsel, Belgium) was used to obtain 
the digital images. The disc height was evaluated by National Institutes 
of Health software. 
2.18. Magnetic resonance imaging (MRI) evaluation 
A 3.0 T MRI scanner (Signa Excite, General Electric Medical Systems, 
Little Chalfont, UK) was used to assessed the IVDD of the rat tail. The 
structure of NP was assessed by T2-weighted sections in a sagittal plane 
at 0 and 16 weeks after injection. We put the rats in the prone position, 
and straightened the tail. The MRI scanner parameters were set as 
follow: spin echo repetition time, 2275 ms; echo time, 80 ms; number of 
excitations, 8; field of view, 5 cm; slice thickness, 1.5 mm; no phase 
wrap. The image slices was analyzed by a GE ADW4.2 workstation. 
Finally, the alteration of NP was evaluated by the Pfirrmann grading 
system [28]. 
2.19. Histological evaluation 
The rats were killed at the indicated time points after micelle injec-
tion, and the intervertebral discs were fixed in 10% formalin, and sliced 
for histologic evaluation. The graded alcohol series and paraffin were 
used to dehydrate, and embed the samples respectively. The slice 
thickness of intervertebral disc was 5 μm sections. Safranin O-fast green 
(S–O) or hematoxylin and eosin (H&E) staining were conducted. Two 
observers in a blinded fashion assessed the cellularity and morphology. 
The grading scale was used as previously reported [29,30]. 
2.20. Immunohistochemistry evaluation 
For immunohistochemistry evaluation, intervertebral disc sections 
were deparaffinized in xylene, and then hydrated with gradient 
increased alcohol. The sections were treated with 3% H2O2 for 15 min 
and 10% goat serum for 15 min. Then the samples were treated with 
mouse monoclonal antibodies against type II collagen at 4 ◦C overnight. 
The samples were incubated with biotin labeled secondary antibody at 
37 ◦C for 30 min, after washing five times with PBS. The SABC method 
was used to detect the staining. Images were recorded by a DP70 CCD 
camera (Olympus) coupled with an AX-70 microscope (Olympus). 
2.21. Statistics 
The data is presented as mean ± S.D. The one-way ANOVA and 
Tukey’s post-hoc test or nonparametric test were used to calculate the 
statistical significance of the differences between the groups. Experi-
ments were repeated at least three times with identical results. All sta-
tistical analysis was performed in SPSS software 22.0 (SPSS Inc., 
Chicago, USA). P < 0.05 was determined as statistical significance. 
3. Results 
3.1. Preparation and characterization of the micelles 
An amphiphilic copolymer PEG-PAPO was synthesized, which could 
self-assemble into a nanosized micelle and load KGN. First, the monomer 
HAPO was synthesized by conjugating APO with HEMA via an ester 
bond. PEG-PAPO was synthesized by Reversible Addition- 
Fragmentation Chain Transfer Polymerization (RAFT) of HAPO with 
PEG-PETTC as the chain transfer agent (Fig. 1A). The formation of PEG- 
PAPO was confirmed by 1H nuclear magnetic resonance (1H NMR) 
(Fig. 1B), which showed that average 16 APOs were linked to a polymer 
chain, whose molecular weight was estimated to be ca.10 kDa. Gel 
permeation chromatography (GPC) of PEG-PETTC and PEG-PAPO 
indicated the copolymer was successfully synthesized with an Mn of 
33 kDa and a polydispersity index (PDI) of 1.17 (Fig. 1C). 
PEG-PAPO could assemble into micelles in aqueous solution, and 
KGN could be effectively loaded into the micelles, forming PAKM, 
because of the hydrophobic properties of APO and KGN and the π-π 
stacking interactions between them. The loading content and efficiency 
tested by HPLC were 3.7% and 38.8%, respectively. PAKM was char-
acterized by dynamic light scattering (DLS). The average-volume hy-
drodynamic diameter was 49.8 nm with a PDI of 0.13, and zeta potential 
of − 34.2 mV (Fig. 1D). APO was gradually released from PAKM under 
the presence of 120 U/mL esterase, while APO was seldomly released 
from PAKM in the absence of esterase (Fig. 1E). However, 90% of the 
loaded KGN was released from the micelle after 4h incubation in PBS 
(Fig. 1F). The above results confirmed the successful drug-loading of the 
micelles and the esterase-responsive APO release property. 
Table 1 
Primers used in quantitative RT-PCR.  
Gene Forward primer (5′–3′) Reverse primer (5′–3′) 
18S CGCCGCTAGAGGTGAAATTC TTGGCAAATGCTTTCGCTC 
COX2 TCCTCAGGCTTGGGTCTTGTT TTCAGGTCACCTTGGTAGGATTTG 
MMP13 ACTGAGAGGCTCCGAGAAATG GAACCCCGCATCTTGGCTT 
SOD GGTGGGCCAAAGGATGAAGAG CCACAAGCCAAACGACTTCC 
KEAP1 CTGGAGGATCATACCAAGCAGG GGATACCCTCAATGGACACCAC 
NRF2 TCAGCGACGGAAAGAGTATGA CCACTGGTTTCTGACTGGATGT 
P62 GCACCCCAATGTGATCTGC CGCTACACAAGTCGTAGTCTGG  
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3.2. Esterase-responsiveness of PAKM 
Esterase activity in human ADSCs (Fig. 2A) was demonstrated by 
fluorescein diacetate (FDA), using methods described in our previous 
research [31]. Our results demonstrated that esterase activity increased 
in human ADSCs after oxidative stimulation by H2O2 compared to the 
control group (Fig. 2B). The increased esterase activity favored the 
esterase-responsive APO release in human ADSCs. 
3.3. Effect of PAKM on the cell viability of H2O2-stimulated human 
ADSCs 
For further investigation, we evaluated the biological effects of De- 
PAKM (degradation products of PAKM acquired using esterase) in vitro. 
Testing for possible cytotoxicity of De-PAKM in human ADSCs, we found 
that cell numbers did not decrease after incubation with De-PAKM 
(Maximally release KGN from 10 to 1000 nM) after 1, 7, and 14 days, 
demonstrating good biocompatibility of De-PAKM with stem cells 
(Fig. 2C). Viability of human ADSCs was analyzed using a Cell Counting 
Kit-8 (CCK-8) assay. After H2O2 exposure (12 h), the viability of human 
ADSCs cultured with APO, KGN, and De-PAKM was investigated 
(Fig. 2D). The viability levels of human ADSCs were 54.1% in H2O2- 
treated group; 68.8% in the KGN + H2O2 group; 77.8% in the APO +
H2O2 group and 89.6% in the De-PAKM + H2O2 group. The data provide 
clear evidence that De-PAKM is an effective tool for improving cell 
viability under H2O2-induced oxidative stress. 
To further confirm these results, ratios of live/dead cells were 
assessed by fluorescence cell imaging. (Fig. 2E). In these assays, H2O2 
treatment increased the numbers of dead cells (red), and reduced the 
numbers of live cells (green). APO-, KGN-, and De-PAKM-treated cells 
showed higher percentage of live cells from all cells, of 91.6%, 92.4%, 
and 97.5%, respectively, under the oxidative stress, than cells treated 
with H2O2 alone (78.8%) (Fig. 2F). 
Apoptotic human ADSCs levels were also evaluated by flow cytom-
etry (Fig. 2G). De-PAKM treatment consistently reduced H2O2-induced 
apoptosis. In contrast, Cell apoptosis rate of human ADSCs was 15.68% 
when treated with H2O2. Apoptosis rate reduced to 5.66% with De- 
PAKM treatment, 11.88% with APO treatment and 14.09% with KGN. 
Therefore, De-PAKM is the effective agent in protecting human ADSCs 
from oxidative stress. 
3.4. Inhibition of inflammatory factor and catabolic gene expression by 
PAKM 
A specific catabolic gene (matrix metalloproteinase-13, MMP-13) is 
essential for IVDD pathogenesis. MMP-13 is the major catabolic factor in 
ECM metabolism [32–34]. The inflammation-associated gene (COX-2) 
in human ADSCs was also studied [35]. To investigate ECM degradation 
in IVDD, we used protein assays to evaluate MMP-13 and COX2 
expression in H2O2 -stimulated human ADSCs treated with De-PAKM 
(Fg. 3A, B). H2O2 stimulation increased the expression of MMP-13 and 
COX-2, but this increase was reduced by KGN, APO, and De-PAKM. In 
Fig. 1. Synthesis and characterization of an esterase-responsive micelle polymer (PAKM) for intervertebral disc degeneration stem cell therapy. (A) The synthesis 
protocol for PEG-PAPO. (B) 1H NMR spectrum (400 MHz, DMSO) of the HAPO and PEG-PAPO. (C) GPC traces of PEG-PETTC, PEG-PAPO. (D) Size distribution of 
PAKM measured by the DLS. (E) APO and (F) KGN was released from the micelle into Dulbecco’s phosphate buffered saline at 37 ◦C. 
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short, De-PAKM shows the greatest ability to resist oxidative 
stress-induced ECM degradation. qRT-PCR analysis also corroborated 
this finding (Fig. 3C). These results indicated that H2O2-induced 
inflammation in human ADSCs was significantly suppressed by 
De-PAKM. 
3.5. PAKM suppressed H2O2-induced oxidative stress 
The antioxidant activity of PAKM was assessed by qRT-PCR analysis. 
We compared expression of the antioxidant enzyme SOD (Fig. 3C) in 
H2O2-treated human ADSCs cultured with APO and KGN, to those 
cultured with De-PAKM; in these conditions, De-PAKM cells showed the 
greatest increase in SOD expression. We also evaluated H2O2-induced 
intracellular ROS production by immunofluorescence analysis, using a 
DCFH-DA probe (Fig. 3E) that can freely cross plasma membranes. 
Intracellular esterase hydrolyses DCFH-DA, and generates dichloro-
fluorescin (DCFH), intracellular ROS oxidizes DCFH and produces 
fluorescent dichlorofluorescein (DCF). Thus, this probe is a sensitive 
indicator of ROS, demonstrating that H2O2 generally induces an increase 
in intracellular ROS in human ADSCs. These results indicate that De- 
PAKM can enhance the ability of human ADSCs to resist oxidative 
stress (Fig. 3D). 
3.6. The differentiation efficiency of human ADSCs in the NP with PAKM 
The matrix-synthesis ability of human ADSCs is demonstrated by the 
gene expression and protein levels of Aggrecan and COL2A1, all of 
which were higher in the PAKM group than the control, H2O2, and 
Fig. 2. PAKM reduced cell apoptosis and maintained cell viability after inflammatory stimulation. (A, B) Esterase activity of human ADSCs with or without H2O2 
stimulation, was determined using fluorescein diacetate, and observed under a fluorescence microscope (Scale bar = 200 μm); (C) Cytotoxicity of PAKM at different 
concentrations on human ADSCs at different time points. (D) Cell viability of cells cultured with KGN and De-PAKM. (E) Fluorescence image of live (green) and dead 
(red) cells with or without H2O2 exposure. (Scale bar = 100 μm) (F) Quantification of percentage of live cells from all cells. (G) Detection of cell apoptosis by flow 
cytometry after treatment with or without H2O2. Data represent the mean ± SD; *p < 0.05 and **p < 0.01 vs the H2O2 group; #p < 0.05 and ##p < 0.01 vs the De- 
PAKM group. Sample numbers N = 3. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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H2O2+APO groups on day 21 (Fig. 3F and G). Previous studies reported 
that positive relationship existed between SOX9 expression and main-
tenance of a healthy ECM [36]. PAKM group also show highest 
expression level of transcription factor SOX9. KRT19 exhibited a high 
nucleus pulposus: annulus fibrosus ratio and a high nucleus pulposus: 
articular cartilage ratio, thus making this a perfect marker for NP cells 
[37]. Human ADSCs cultured with PAKM shows higher KRT19 levels 
compared to either the KGN or APO treatment group. Safranin-O 
staining and fluorescence microscopy observation of COL2A1 indi-
cated that PAKM significantly induces differentiation of human ADSCs 
into an NP-like phenotype (Fig. S1). All these data demonstrate that 
PAKM has a strong ability to inhibit ECM degradation and to induce 
nucleus pulposus differentiation of human ADSCs under oxidative stress. 
Fig. 3. Suppression of H2O2-induced oxidative stress and extracellular matrix release from human ADSCs. (A, B) Western blot detection for MMP-13 and COX2 in 
human ADSCs cultured with De-PAKM. (C). qRT-PCR detection of inflammatory factors MMP-13, COX2 and antioxidant factors SOD in human ADSCs cultured with 
De-PAKM. (D) Quantification of relative ROS strength. (E) Intracellular ROS detection with dichloro-dihydro-fluorescein diacetate (DCFH-DA) obtained by immu-
nofluorescence staining. (F) Protein expression levels of SOX9, Aggrecan, COL2, and KRT19 were measured on day 21. (G) Representative Western blot images and 
quantification of expression levels are shown. GAPDH served as a loading control. Data represent the mean ± SD; *p < 0.05 and **p < 0.01 vs the H2O2 group; #p <
0.05 and ##p < 0.01 vs the De-PAKM group. Sample numbers N = 3. 
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3.7. PAKM activated autophagy 
Autophagy plays a crucial role in removal of dysfunctional organelles 
and protein aggregates in maintaining stem-cell homeostasis, and can 
assist cells in resisting excessive oxidative stress in IVDD [38–40]. The 
presence of autophagosomes is an indication of autophagy. We detected 
the presence of autophagosomes by immunofluorescence (Fig. 4C) of 
LC3 II. There are fewer autophagic vacuoles in the absence of H2O2 
stimulation. After exposure to H2O2 for 24 h, human ADSCs cultured 
with De-PAKM shows more dots of LC3 II, thus indicating the presence of 
autophagosomes, compared to that of cells cultured with APO and KGN 
group (Fig. 4D). These results show that De-PAKM activated autophagy 
in human ADSCs more effectively than other treatments. We also eval-
uated protein and gene expression levels of the autophagy markers 
KEAP1, LC3 II, and P62 (Fig. 4A, B, E). In contrast to APO and KGN 
treatment, the LC3 II expression levels were significantly up-regulated in 
De-PAKM-treated cells. Notably, KEAP1 and P62 was suppressed in 
De-PAKM group. The KEAP1-NRF2 system plays a key role in the 
adjustment of redox homeostasis [41], and the NRF2 signaling pathway 
is negatively regulated by KEAP1 in autophagy under oxidative stress. 
Therefore, our results suggest that De-PAKM suppressed H2O2-induced 
oxidative stress in human ADSCs by activating autophagy. 
3.8. Disc height assessment in different groups by X-ray and MRI analysis 
Intervertebral disc height was evaluated by X-ray analysis to assess 
the treatment effects of PAKM in vivo (Fig. 5A and B). The disc height 
index (DHI%) value of the control, disc degeneration, PAKM, and 
PAKMA group were significantly decreased at all time points compared 
with that of the control group. The DHI% values of the degeneration, 
PAKM, and PAKMA groups showed no obvious differences at week 0; 
however, at16 weeks, the PAKMA group showed much stronger treat-
ment effects than that the PAKM and degeneration group (p < 0.01) 
(Fig. 5C). MRI is an efficient method for evaluating the water content 
and composition of intervertebral discs (Fig. 5D). According to the 
Pfirrmann grading system [28], the severity of IVDD in the four groups 
was totally different at 16 weeks after treatment (χ2 = 51.33, P < 0.001) 
(Fig. 5E). At 16 weeks, PAKMA group showed four IVDs graded II, two 
IVDs graded III. Meanwhile, the degenerative group without treatment 
showed the most severe degeneration (grade IV = 1, grade V = 5 at 16 
weeks). 
3.9. Histological and immunohistochemical evaluation of intervertebral 
discs 
The control group showed complete NP structure and collagen 
arrangement in the annulus fibrosus (Fig. 6A). In the degeneration 
group, however, intervertebral disc structure was destroyed. The con-
tents of the intervertebral disc were decreased with disorganized 
hypocellular fibrocartilaginous tissue. Although discs in the PAKMA 
group were degraded to some extent, the PAKMA group exhibited more 
complete disc morphology than the PAKM and degeneration groups. The 
Fig. 4. Autophagy activation by De-PAKM protect human ADSCs from H2O2-induced oxidative stress. (A, B) Western blot detection for P62 and LC3II in human 
ADSCs cultured with PAKM. (C) Fluorescence microscopy observation of LC3 (green) in human ADSCs after treatment with H2O2. (D) Quantification of LC3IIdots/ 
cell. (E) qRT-PCR detection of expression levels of autophagy markers KEAP1, NRF2, and P62. Data represent the mean ± SD; *p < 0.05 and **p < 0.01 vs the H2O2 
group; #p < 0.05 and ##p < 0.01 vs the De-PAKM group. Sample numbers N = 3. (For interpretation of the references to colour in this figure legend, the reader is 
referred to the Web version of this article.) 
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PAKMA group, for instance, showed no evidence of incursion of blood 
vessels within the discs. Safranin-O staining demonstrated a decrease in 
proteoglycans in the degeneration, PAKM, and PAKMA groups. PAKMA 
showed less disc degeneration than the PAKM group (Fig. 6B), and the 
histologic scores of the PAKMA group, evaluated by the methods 
described in Table S1 [9], was significantly lower than the PAKM and 
degeneration groups (Fig. 6D). The PAKM group showed evidence of 
partial damage repair, and the PAKMA group showed evidence of 
marked improvement. The control group contained well-organized type 
II collagen, proved by Immunohistochemical staining (Fig. 6C). At 16 
weeks, type II collagen staining in the degeneration and PAKM groups 
was lower than that in the PAKMA group, proving a lack of disc structure 
in the first two groups, and a more normal structure in PAKMA group. 
4. Discussion 
In this study, we have proposed a novel strategy for treatment of 
IVDD. The mechanism and effectiveness of the proposed therapy was 
carefully validated both in vitro (human ADSCs) and in vivo (a rat IVDD 
model). As the core of our strategy for IVDD treatment, we designed an 
APO-based amphiphilic micelle, which was readily synthesized by 
linking APO monomer via an esterase-responsive phenolic ester bond 
and loading lipophilic KGN in the core of the micelle. Our work dem-
onstrates that PAKM could protect human ADSCs from oxidative stress, 
and promote human ADSCs differentiation into an NP-like phenotype. 
Stem cell transplantation therapy is a promising strategy for IVDD 
treatment. Human ADSCs are multipotent cells characterized by their 
ability to differentiate into adipocytes, chondrocytes, and osteoblasts 
[42]. Previous studies have demonstrated the beneficial effect of 
Fig. 5. Disc height indices were measured from 
digitized radiographs using NIH software (A, B) 
Representative radiographs of the rat Co7/Co8 and 
Co8/Co9 were obtained from the four groups at 4 
and 16 weeks after injection. (C) Disc height 
changes of the four groups were measured at 
different time points. (D) Representative T2 MRI 
scans of different groups were obtained at 0 and 16 
weeks. (E) The Pfirrmann grading system of 
different experimental groups were used to quantify 
the structure, distinction of nucleus and annulus 
fibrosus, signal intensity, and height of interverte-
bral disc (χ2 = 51.33, P < 0.001). PAKM (with 
needle puncture and PAKM injection); PAKM with 
human ADSCs group (PAKMA) (with needle punc-
ture and PAKM with human ADSCs injection. Data 
represent the mean ± SD; *p < 0.05 and **p < 0.01 
vs the control group; ##p < 0.01 and ###p <
0.001 vs the PAKMA group. Sample numbers N = 6.   
Fig. 6. (A, B) Representative images of H&E and SO 
staining of different groups obtained at 0, 4, 8, and 
16 weeks after injection. (C) Immunohistochemical 
detection of type II collagen in the intervertebral 
disc from different groups at 16 weeks after injec-
tion. (D) A histogram showing the histological 
scores of four groups evaluated at 16 weeks after 
injection. PAKM (with needle puncture and PAKM 
injection); PAKM with human ADSCs group 
(PAKMA) (with needle puncture and PAKM with 
human ADSCs injection. Data represent the mean ±
SD; *p < 0.05 and **p < 0.01 vs the control group; 
#p < 0.05 and ##p < 0.01 vs the PAKMA group. 
Sample numbers N = 6.   
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mesenchymal stem cells on intervertebral disc degeneration [43–45]. 
But there are still many problems between the microenvironment and 
transplanted cells. Although some ROS serve as signaling molecules in 
cells, excessive oxidative and inflammation production is harmful and 
has been implicated in progression of IVDD [46]. ROS production and 
nonspecific inflammation generated during the IVDD pathological pro-
cess have been demonstrated in leading to loss of transplanted stem 
cells. In conclusion, cellular damage and dysfunction occur with high 
ROS levels. Therefore, Attenuation of ROS-induced cell apoptosis and 
promotion of cell differentiation were essential for getting greater 
clinical success in cell transplantation therapy [47,48]. 
The anti-aging and anti-apoptotic capability of APO in mesenchymal 
stem cells has been reported on intracerebral hemorrhage and myocar-
dial infarction [23,24]. Our study first confirmed that APO stimulated 
the proliferation and survival rate of human ADSCs on IVDD. Secondly, 
KGN was reported to effectively repair the degeneration of interverte-
bral disc. Yao et al. demonstrated the effects of KGN on the attenuated 
nucleus pulposus cell degeneration induced by interleukin-1β and tumor 
necrosis factor-α [49]. Zhu et al. shown developed the KGN-conjugated 
chitosan–hyaluronic acid hydrogel, which promote human ADSCs pro-
liferation and nucleus pulposus differentiation [25]. Although above 
studies shown regenerative effects of IVDD to a certain extent, excessive 
oxidative stress in the lesion site still causes hyper-peroxidation, protein 
carbonylation and DNA damage to transplanted human ADSCs. Impor-
tantly, we have herein demonstrated that the antioxidant PAKM in-
creases human ADSCs viability by reducing inflammation factors 
(COX2, MMP-13), suppressing ROS, and activating antioxidant enzymes 
(SOD). In addition, APO and KGN released from our micelles stimulate 
autophagy via KEAP1-NRF2 axis. P62 phosphorylates and interacts with 
the NRF2-binding site of KEAP1, inhibiting KEAP1-NRF2 interaction, 
and resulting in upregulation of these genes under oxidative stress. 
Previous research demonstrated that KGN promotes silent information 
regulator type 1 (SIRT1) expression to enhance the intracellular anti-
oxidant properties of mesenchymal stem cells [50]. There may thus exist 
a positive feedback loop between SIRT1 and KEAP1/NRF2 
anti-oxidative pathway to suppress ROS overproduction [51]. The pos-
itive feedback loop discussed above may explain the anti-oxidative 
ability of KGN. Furthermore, histological and immunohistochemical 
data confirm that the PAKM micelles effectively suppress IVDD pro-
gression and nucleus pulposus degradation, and this is the main purpose 
of our study to protect human ADSCs from oxidative stress. 
KRT19 is specifically expressed in cells with an NP-like phenotype. 
Meanwhile, the COL2, Aggrecan genes can be used for evaluating the 
extracellular matrix releasing ability of differentiated cells [37]. 
Therefore, the differentiation and extracellular matrix releasing ability 
of human ADSCs can be effectively evaluated using these genes in this 
study. 
PAKM, combined with human ADSCs injection, has been shown to be 
a minimally invasive strategy for nucleus pulposus repair that is appli-
cable to IVDD treatment. However, the sustained release profile of mi-
celles has this far been tested only in vitro. Further assessment is needed 
to measure the quantity of APO and KGN content in the discs. Our 
previous studies described a tail disc degeneration model generated via 
acupuncture [27]. This animal model facilitates injection of micelles 
into the injury area, and histologic and radiographic signs of disc 
degeneration can be successfully monitored. In IVDD, disc height, water 
content, ECM, and NP cell number all decrease [3]. Our results show that 
injection of PAKM with human ADSCs yields better treatment results 
than in the degeneration and PAKM groups. In the degeneration group, 
intervertebral discs structures were obviously destroyed. Our study 
evaluated the morphology of the AF and NP were evaluated by histo-
logical score. The histological score of the PAKMA group was signifi-
cantly lower than that of either the PAKM or the degeneration group. 
Although IVDD degeneration was indeed attenuated in the PAKMA 
group, its histological score was still higher than that in control group. In 
conclusion, injection of PAKM has no obvious activity on alleviating 
IVDD. Though the PAKMA partially alleviated IVDD, it presented a 
better treatment activity on alleviating IVDD than the PAKM group. This 
result may be due to the influence of APO and KGN on human ADSCs, 
which affect scavenging ROS, reducing cell apoptosis and maintaining 
the differentiation potential of human ADSCs. 
Although histology and imaging data indicate that the PAKM mi-
celles injected with human ADSCs provided better treatment effects than 
the other groups, even in this group, normal intervertebral disc capa-
bilities were not recovered completely. Several studies shown that, 
although high ROS levels cause cellular damage and dysfunction, a low 
basal level of ROS is necessary to maintain normal cellular proliferation, 
differentiation, and survival. Further investigation is needed to fully 
clarify the necessary balance between ROS and stem cells. Our work has 
shown that dramatically increased ROS production leads to loss of 
transplanted mesenchymal stem cells from this site. The injectable 
PAKM micelle is an effect tool to maximize the biological effects and 
survival rate of stem cells. Finally, micro CT, flexibility tests, and axial 
compression tests are also reliable strategies for evaluating the effect of 
biological therapies. 
5. Conclusions 
In our study, an injectable esterase-responsive KGN load PAPO 
micelle PAKM was developed to codelivery APO and KGN into inter-
vertebral discs. The results demonstrate the biosafety of PAKM, and its 
ability to stimulate differentiation of human ADSCs and to protect cells 
by suppressing oxidative stress. As a result, PAKM combined with 
human ADSCs could alleviate IVDD in vivo, providing a novel strategy in 
developing biological therapies for IVDD. 
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